ScreenPoint Medical Expands Breast Cancer Risk Assessment with Biomediq Acquisition ScreenPoint Medical has expanded its breast cancer risk assessment capabilities through the acquisition of Biomediq A/S, enhancing its AI technology for improved detection.

ScreenPoint Medical Expands Breast Cancer Risk Assessment with Biomediq Acquisition #Netherlands #Breast_Cancer #ScreenPoint #Nijmegen #Biomediq

New FDA Approval for Transpara AI Enhances Breast Cancer Detection at RSNA ScreenPoint Medical unveils new FDA-approved capabilities of its AI tool, Transpara, aimed at improving breast cancer detection during RSNA 2024.

New FDA Approval for Transpara AI Enhances Breast Cancer Detection at RSNA #USA #AI #Chicago #Transpara #ScreenPoint

Revolutionizing Breast Cancer Detection: Transpara's FDA Clearance at RSNA 2024 ScreenPoint Medical unveils FDA-cleared advancements to Transpara, enhancing breast cancer detection and streamlining radiology workflows at RSNA 2024.

Revolutionizing Breast Cancer Detection: Transpara's FDA Clearance at RSNA 2024 #United_States #Chicago #Transpara #Breast_AI #ScreenPoint